Lilly vs Pfizer: Obesity Race Reaches Market Highs
Lilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
Using Index Level to adjust risk lets you scale exposure in line with market momentum, maintaining a balanced, rules-based approach.
27,393 articlesLilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
Nvidia is fueling a bold thesis for H2 2026 as AI infrastructure demand climbs. With data-center momentum and locked-...
In a choppy market, one defense contractor shines as a rare dividend stock built for downturns. Its government-backed...
US-regulated crypto perps are live, moving from approval to execution as Kalshi launches a multi-asset perpetual futu...
Retirees with $1.3 million are recalibrating portfolios for steady income as markets swing. This piece highlights thr...
Chip shares jumped as risk appetite returned to markets, with Intel and AMD leading a broader move higher on AI infra...
A two-day injunction hearing opens in federal court in Chicago as Zillow fights to keep access to the Chicagoland MLS...
A civil judgment against a high-profile entertainer is piling up daily, turning an initial $4.2 million award into a ...
Ripple secures full authorization under MiCA from Luxembourg's CSSF, enabling its XRP-based payments platform to oper...
Sen. Mitch McConnell remains hospitalized as Republicans grapple with a slim Senate majority ahead of the November mi...
New market data challenge the idea that AI spending is peaking. AI infrastructure is expanding, with implications for...
SandboxAQ CEO urges the United States to adopt a sovereign wealth fund strategy akin to Norway’s model. The call come...